Detalhe da pesquisa
1.
Downstream of the HOX genes: Explaining conflicting tumour suppressor and oncogenic functions in cancer.
Int J Cancer
; 150(12): 1919-1932, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35080776
2.
Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib.
BJU Int
; 128(2): 254-261, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33547860
3.
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy.
N Engl J Med
; 375(23): 2246-2254, 2016 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27718781
4.
Induction of trismus by sunitinib and pazopanib in metastatic renal cell carcinoma.
Indian J Urol
; 33(1): 76-78, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28197036
5.
HOX transcription factors are potential targets and markers in malignant mesothelioma.
BMC Cancer
; 16: 85, 2016 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26867567
6.
Targeting HOX transcription factors in prostate cancer.
BMC Urol
; 14: 17, 2014 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-24499138
7.
The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway.
Int J Cancer
; 133(4): 879-92, 2013 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23400877
8.
Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI-001 in inâ vitro Models of Prostate Cancer Drug Resistance.
ChemMedChem
; 18(2): e202200548, 2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36300876
9.
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors.
J Immunother Cancer
; 11(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36669791
10.
Are we ready to start studies of Th17 cell manipulation as a therapy for cancer?
Cancer Immunol Immunother
; 61(1): 1-7, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22086162
11.
Targeting the HOX/PBX dimer in breast cancer.
Breast Cancer Res Treat
; 136(2): 389-98, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23053648
12.
Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway.
BMC Cancer
; 12: 368, 2012 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-22920673
13.
Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial.
Nat Commun
; 13(1): 5959, 2022 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36216827
14.
Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer.
BMC Cancer
; 11: 221, 2011 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-21645351
15.
Reciprocal human dendritic cell-natural killer cell interactions induce antitumor activity following tumor cell infection by oncolytic reovirus.
J Immunol
; 183(7): 4312-21, 2009 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19734207
16.
Antiangiogenic effects of zoledronate on cancer neovasculature.
Future Oncol
; 7(11): 1325-33, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22044205
17.
The effect of cell cycle synchronization on tumor sensitivity to reovirus oncolysis.
Mol Ther
; 18(12): 2085-93, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20842107
18.
Therapeutic effect of sodium iodide symporter gene therapy combined with external beam radiotherapy and targeted drugs that inhibit DNA repair.
Mol Ther
; 18(9): 1599-605, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20588260
19.
HOX genes in pancreatic development and cancer.
JOP
; 12(3): 216-9, 2011 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-21546695
20.
Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo.
BMC Cancer
; 10: 486, 2010 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-20836854